Expiratory Flow Accelerator (Efa) vs Efa + High Flow in Chronic COPD and Bronchiectasis

Azienda Socio Sanitaria Territoriale della Valle Olona20 enrolled

Overview

The aim of the study is to compare the efficacy of using EFA technology versus the combination of EFA + high flow in hypersecretory patients COPD and bronchiectasis

After being informed about the study and potential risks, all patients giving written informed consent will undergo a 13-weeks trial period: 6 weeks of one technology (EFA / EFA+ HIGH FLOW), 1- wash out week and 6- weeks of the other technology in a cross over randomized trial.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

PREVENTION

Masking

NONE

Enrollment

Conditions

Copd Bronchiectasis Adult

Interventions

Bronchial Clearance ADEVICE

EFA technology: the patient has to breathe at tidal volume by a mouthpiece at level 5 for half an hour twice a day.

Bronchial Clearance BDEVICE

High Flow Technology: patient has to wear nasal cannula and breathe his nose for one hour twice a day. After he has to use EFA technology level 5 for half an hour twice a day.

Eligibility

Sex: ALLMin age: 18 YearsMax age: 95 Years

Medical Language ↔ Plain English

Inclusion Criteria: * COPD diagnosed by spirometry * Bronchiectasis diagnosed by CT * 2 Exacerbation/year Exclusion Criteria: * Cystic Fibrosis * OSAS * Non Invasive Ventilation * Ineffective Cough * Exacerbation in progress * Hemodynamic Instability * severe heart failure

Locations (1)

Marianna Messina

Somma Lombardo, Varese, Italy

RECRUITING